GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

Surging Demand for Non-Pharmacological Therapies and Advancements in Neurostimulation Technologies Fuel Market Expansion ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Penile implant surgery helps people have and maintain an erection. Penile implants may be suitable for people with erectile dysfunction that has not responded to other treatments or as part of ...

PNC Financial Services Group Inc. lifted its position in Nevro Corp. (NYSE:NVRO – Free Report) by 62.3% during the fourth quarter, according to its most recent 13F filing with the Securities and ...

StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

The newest generation of orthopaedic robots, will reduce the cost of surgery. Credit: VesnaArt via Shutterstock. Robotic orthopaedic surgery is rapidly evolving, driven by precision, personalisation ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...

While the overall implant failure rate was relatively low (5.67% over two years), understanding these risk factors is essential for both patients and clinicians to optimize treatment success.